文献速递肝病

利用药物性肝损伤网络数据库对Hy定律的细化

Refinement of Hy Law Using the Drug-Induced Liver Injury Network Database.
PubMed 文献 · Am J Gastroenterol · 2024-10-18

该研究基于前瞻性药物性肝损伤网络(DILIN)队列,分析≥10例确诊黄疸性DILI病例的药物,采用四种Hy定律排列评估其有效性。结果显示初始R值最可靠,肝细胞型DILI死亡率11.1% vs 胆汁淤积/混合型2.0%(P<0.001),但部分药物致肝细胞损伤伴黄疸死亡率<10%,Hy定律需细化。

要点

  • 初始R值是最可靠识别Hy定律病例的方法。
  • 初始R值下肝细胞型死亡率11.1% vs 胆汁淤积/混合型2.0%(P<0.001)。
  • 部分药物致肝细胞损伤伴黄疸死亡率<10%。

核心结论

  • 初始R值是识别Hy定律病例最可靠的方法。
  • 存在一些引起肝细胞损伤伴黄疸但死亡率<10%的药物。
  • Hy定律需要细化。

研究设计与样本

  • 基于前瞻性药物性肝损伤网络(DILIN)队列的分析。
  • 纳入≥10例确诊黄疸性DILI病例的药物。
  • 应用四种Hy定律排列:初始或峰值R≥5,以及FDA相关标准(初始或峰值ALT或AST≥3倍ULN且ALP≤2倍ULN)。

主要发现

  • 使用初始R值,肝细胞型死亡率11.1% vs 胆汁淤积/混合型2.0%(P<0.001)。
  • 使用峰值R值,肝细胞型死亡率10.3% vs 胆汁淤积/混合型1.6%(P<0.001)。
  • 使用FDA相关定义初始值,肝细胞型死亡率7.9% vs 胆汁淤积/混合型3.9%(P=0.04)。
  • 使用FDA相关定义峰值,肝细胞型死亡率7.9% vs 胆汁淤积/混合型3.0%(P=0.01)。
  • 使用初始R值,常引起肝细胞损伤的药物死亡率一般≥10%,而通常引起胆汁淤积/混合型损伤的药物死亡率均<10%。

关键数值与推荐

  • Hy定律:肝细胞型DILI伴黄疸死亡率≥10%。
  • R≥5使用初始或峰值ALT、AST和ALP水平。
  • FDA相关标准:ALT或AST≥3倍ULN且ALP≤2倍ULN,使用初始或峰值。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Hyman Zimmerman observed that hepatocellular (HC) drug-induced liver injury (DILI) with jaundice had a mortality rate of ≥ 10% (Hy Law). Hy Law does not specify the timing of liver tests nor the definition of HC DILI versus cholestatic or mixed (C/M) DILI. We aimed to assess the validity of Hy Law in the prospective DILI Network (DILIN) cohort. METHODS: Drugs with ≥10 confirmed DILI cases with jaundice were analyzed. Four permutations of Hy Law were applied: R ≥ 5 using initial (1) or peak (2) alanine aminotransferase, aspartate aminotransferase and alkaline phosphatase levels, and the Food and Drug Administration associated criteria of alanine aminotransferase or aspartate aminotransferase ≥ 3x upper limit of normal with alkaline phosphatase ≤ 2x upper limit of normal using initial (3) or peak values (4). Mortality was death or liver transplant adjudicated to be due to DILI. RESULTS: Using initial R values, mortality was 11.1% for HC vs 2.0% for C/M ( P < 0.001); using peak R values, mortality was 10.3% vs 1.6% ( P < 0.001). Using Food and Drug Administration-associated definition, mortality was 7.9% vs 3.9% ( P = 0.04) using initial values and 7.9% vs 3.0% ( P = 0.01) using peak values. Using initial R values, drugs that frequently caused HC injury generally had mortality rates ≥ 10%, while drugs that typically caused C/M injury all had rates < 10%. Occasional agents that caused HC injury with jaundice were associated with low mortality. DISCUSSION: Initial R values were the most reliable means of identifying Hy Law cases. There were some drugs that caused HC injury with jaundice but with mortality rates < 10%. Refinement of Hy Law is warranted.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Barritt AS, Hayashi PH, Stolz AA, et al. Refinement of Hy Law Using the Drug-Induced Liver Injury Network Database. Am J Gastroenterol. 2024. PMID: 39422332. doi:10.14309/ajg.0000000000003145

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。